Neuroprotective Agents

Neuroprotective Agents is a class of pharmacological compounds that belong to the broader category of therapeutic agents used in neurodegenerative disease pharmacology, distinguished by their ability to slow, halt, or reverse neuronal damage and loss through mechanisms that mitigate neurotoxic, inflammatory, excitotoxic, or oxidative insults to the central nervous system.

11.8K

Publications

618.2K

Citations

53.8K

Authors

6.5K

Institutions

Publications per year

2017–2026

4.6K

Variants

NeuroprotectantsNeuroprotective Drugs

Authors

53.8K

  1. MB
    Moussa B. H. Youdim

    Technion – Israel Institute of Technology, Israel

    69 publications · 6.9K citations

    46

    h-index

  2. MG
    Manuela G. López

    Universidad Autónoma de Madrid, Spain

    39 publications · 2.6K citations

    29

    h-index

  3. AK
    Anil Kumar

    Panjab University, India

    34 publications · 1.9K citations

    28

    h-index

  4. TA
    Tamar Amit

    Technion – Israel Institute of Technology, Israel

    34 publications · 3.4K citations

    27

    h-index

  5. JM
    José Marco‐Contelles

    Instituto de Química Orgánica General, Spain

    43 publications · 1.8K citations

    26

    h-index

1–5 of 53.8K

Venues

  1. Journal of Neurochemistry

    JNC · 252 publications · 21.5K citations

    86

    h-index

  2. Stroke

    137 publications · 12.8K citations

    75

    h-index

  3. Journal of Neuroscience

    97 publications · 17.2K citations

    74

    h-index

  4. Brain Research

    249 publications · 15.5K citations

    72

    h-index

  5. PLoS ONE

    219 publications · 12K citations

    65

    h-index

1–5